{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:57:18Z","timestamp":1762869438373,"version":"3.37.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04036-3","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T19:01:43Z","timestamp":1726686103000},"page":"468-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Excellent RAI therapeutic response on a patient presenting skull metastasis of follicular thyroid cancer after 15 years"],"prefix":"10.1007","volume":"87","author":[{"given":"A.","family":"Carbone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Verrienti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. S.","family":"Cito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"4036_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1677\/ERC-07-0229","volume":"15","author":"MM Muresan","year":"2008","unstructured":"M.M. Muresan, P. Olivier, J. Lecl\u00e8re, F. Sirveaux, L. Brunaud, M. Klein, R. Zarnegar, G. Weryha, Bone metastases from differentiated thyroid carcinoma. Endocr. Relat. Cancer. 15, 37\u201349 (2008). https:\/\/doi.org\/10.1677\/ERC-07-0229","journal-title":"Endocr. Relat. Cancer."},{"key":"4036_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/THY.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/THY.2015.0020","journal-title":"Thyroid"},{"key":"4036_CR3","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00259-022-05697-w","volume":"49","author":"A Jannin","year":"2022","unstructured":"A. Jannin, L. Lamartina, C. Moutarde, M. Djennaoui, G. Lion, B. Chevalier, M.C. Vantyghem, F. Deschamps, J. Hadoux, E. Baudin, M. Schlumberger, S. Leboulleux, C. Do Cao, Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival. Eur. J. Nucl. Med. Mol. Imaging. 49, 2401\u20132413 (2022). https:\/\/doi.org\/10.1007\/s00259-022-05697-w","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"4036_CR4","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J.P. Travagli, B. Caillou, M. Ricard, J.D. Lumbroso, F. De Vathaire, M. Schlumberger, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892\u20132899 (2006). https:\/\/doi.org\/10.1210\/jc.2005-2838","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4036_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12020-017-1455-6","volume":"59","author":"G Mazziotti","year":"2018","unstructured":"G. Mazziotti, A.M. Formenti, M.B. Panarotto, E. Arvat, A. Chiti, A. Cuocolo, M.E. Dottorini, C. Durante, L. Agate, S. Filetti, F. Felicetti, A. Filice, L. Pace, T. Pellegrino, M. Rodari, M. Salvatori, C. Tranfaglia, A. Versari, D. Viola, S. Frara, A. Berruti, A. Giustina, R. Giubbini, Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. Endocrine 59, 90\u2013101 (2018). https:\/\/doi.org\/10.1007\/s12020-017-1455-6","journal-title":"Endocrine"},{"key":"4036_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3238\/arztebl.2015.0452","volume":"112","author":"R Paschke","year":"2015","unstructured":"R. Paschke, T. Lincke, S.P. M\u00fcller, M.C. Kreissl, H. Dralle, M. Fassnacht, The treatment of well differentiated thyroid carcinoma. Dtsch. Arztebl. Int. 112, 452\u2013458 (2015). https:\/\/doi.org\/10.3238\/arztebl.2015.0452","journal-title":"Dtsch. Arztebl. Int."},{"key":"4036_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/SLA.0b013e3181b7faf6","volume":"251","author":"J Lee","year":"2010","unstructured":"J. Lee, E.Y. Soh, Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis: Clinical outcomes and prognostic factors. Ann. Surg. 251, 114\u2013119 (2010). https:\/\/doi.org\/10.1097\/SLA.0b013e3181b7faf6","journal-title":"Ann. Surg."},{"key":"4036_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13215422","volume":"13","author":"M Steinschneider","year":"2021","unstructured":"M. Steinschneider, J. Pitaro, S. Koren, Y. Mizrakli, C. Benbassat, L.M. Kalmovich, Differentiated thyroid cancer with biochemical incomplete response: Clinico-pathological characteristics and long term disease outcomes. Cancers (Basel) 13, 1\u20139 (2021). https:\/\/doi.org\/10.3390\/cancers13215422","journal-title":"Cancers (Basel)"},{"key":"4036_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1089\/thy.2011.0232","volume":"21","author":"F Vaisman","year":"2011","unstructured":"F. Vaisman, H. Tala, R. Grewal, R.M. Tuttle, In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21, 1317\u20131322 (2011). https:\/\/doi.org\/10.1089\/thy.2011.0232","journal-title":"Thyroid"},{"key":"4036_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12020-019-02142-1","volume":"67","author":"J Ahn","year":"2020","unstructured":"J. Ahn, E. Song, W.G. Kim, T.Y. Kim, W.B. Kim, Y.K. Shong, M.J. Jeon, Long-term clinical outcomes of papillary thyroid carcinoma patients with biochemical incomplete response. Endocrine 67, 623\u2013629 (2020). https:\/\/doi.org\/10.1007\/s12020-019-02142-1","journal-title":"Endocrine"},{"key":"4036_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvaa178","volume":"5","author":"AS Alzahrani","year":"2021","unstructured":"A.S. Alzahrani, Y. Moria, N. Mukhtar, H. Aljamei, S. Mazi, L. Albalawi, A. Aljomaiah, Course and predictive factors of incomplete response to therapy in low- and intermediate-risk thyroid cancer. J. Endocr. Soc. 5, 1\u201310 (2021). https:\/\/doi.org\/10.1210\/jendso\/bvaa178","journal-title":"J. Endocr. Soc."},{"key":"4036_CR12","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"S. Filetti, C. Durante, D. Hartl, S. Leboulleux, L.D. Locati, K. Newbold, M.G. Papotti, A. Berruti, Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30, 1856\u20131883 (2019). https:\/\/doi.org\/10.1093\/annonc\/mdz400","journal-title":"Ann. Oncol."},{"key":"4036_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2015.09.011","volume":"53","author":"A Lipton","year":"2016","unstructured":"A. Lipton, K. Fizazi, A.T. Stopeck, D.H. Henry, M.R. Smith, N. Shore, M. Martin, S. Vadhan-Raj, J.E. Brown, G.E. Richardson, F. Saad, D.A. Yardley, K. Zhou, A. Balakumaran, A. Braun, Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. Eur. J. Cancer. 53, 75\u201383 (2016). https:\/\/doi.org\/10.1016\/j.ejca.2015.09.011","journal-title":"Eur. J. Cancer."},{"key":"4036_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1365-2265.2002.01482.x","volume":"56","author":"G Zettinig","year":"2002","unstructured":"G. Zettinig, B.J. Fueger, C. Passler, K. Kaserer, C. Pirich, R. Dudczak, B. Niederle, Long\u2010term follow\u2010up of patients with bone metastases from differentiated thyroid carcinoma \u2013 surgery or conventional therapy? Clin. Endocrinol. (Oxf). 56, 377\u2013382 (2002). https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01482.x","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"4036_CR15","first-page":"598","volume":"37","author":"M Schlumberger","year":"1996","unstructured":"M. Schlumberger, C. Challeton, F. De Vathaire, J.P. Travagli, P. Gardet, J.D. Lumbroso, C. Francese, F. Fontaine, M. Ricard, C. Parmentier, Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J. Nucl. Med. 37, 598\u2013605 (1996)","journal-title":"J. Nucl. Med."},{"key":"4036_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/BF02067343","volume":"16","author":"CAG Proye","year":"1992","unstructured":"C.A.G. Proye, D.H.R. Dromer, B.M. Carnaille, A.J.P. Gontier, A. Goropoulos, P. Carpentier, J. Lefebvre, M. Decoulx, J.L. Wemeau, P. Fossati, C. Sulman, Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine? World J. Surg. 16, 640\u2013645 (1992). https:\/\/doi.org\/10.1007\/BF02067343","journal-title":"World J. Surg."},{"key":"4036_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s002590000420","volume":"28","author":"T Petrich","year":"2001","unstructured":"T. Petrich, A. Widjaja, T.J. Musholt, M. Hofmann, T. Brunkhorst, C. Ehrenheim, G. Oetting, W.H. Knapp, Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: Side-effects and influence of age. Eur. J. Nucl. Med. 28, 203\u2013208 (2001). https:\/\/doi.org\/10.1007\/s002590000420","journal-title":"Eur. J. Nucl. Med."},{"key":"4036_CR18","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jc.2011-0093","volume":"96","author":"ZL Qiu","year":"2011","unstructured":"Z.L. Qiu, H.J. Song, Y.H. Xu, Q.Y. Luo, Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 96, 3078\u20133086 (2011). https:\/\/doi.org\/10.1210\/jc.2011-0093","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4036_CR19","doi-asserted-by":"crossref","unstructured":"C.S. Kumar, D. Shanmugam, R. Venkatapathy, M. Ahmed, I. Munshi, Metastatic follicular carcinoma of thyroid in maxilla. Dental. Res. J. (Isfahan) 10, 817\u2013819 (2013)","DOI":"10.4103\/0973-0354.105848"},{"key":"4036_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.20945\/2359-3997000000004","volume":"62","author":"I Califano","year":"2018","unstructured":"I. Califano, S. Deutsch, A. L\u00f6wenstein, C. Cabez\u00f3n, F. Pitoia, Outcomes of patients with bone metastases from differentiated thyroid cancer. Arch. Endocrinol. Metab. 62, 14\u201320 (2018). https:\/\/doi.org\/10.20945\/2359-3997000000004","journal-title":"Arch. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04036-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:29:45Z","timestamp":1739190585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04036-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["4036"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04036-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}